文献速递细菌感染、耐药与抗菌药物医院感染防控

抗菌药物管理干预效果评估的适宜科学方法:叙述性综述

Good epidemiological practice: a narrative review of appropriate scientific methods to evaluate the impact of antimicrobial stewardship interventions.
PubMed 文献 · Clin Microbiol Infect · 2017-05-29

该叙述性综述基于Cochrane与Pubmed文献,提出评估抗菌药物管理(AMS)干预证据质量的框架,并指导未来AMS评价研究的设计与规划。文章指出AMS多在复杂真实环境中实施,偏倚与随机时间效应可危及因果推断效度,建议采用整群随机对照试验(cRCT)或含对照组的间断时间序列(ITS)设计,并全面报告预期与非预期后果及过程评价。

要点

  • AMS干预评估应优先选择cRCT或含对照组的ITS设计以控制偏倚。
  • 同质干预与对照组的随机化可限制同步感染防控策略及均值回归等风险。
  • 应同时纳入过程、临床结局、微生物学与经济学多类指标以发现非预期后果。

核心结论

  • 未来评估新型AMS策略的研究应通过选择cRCT或含对照组的ITS产生有力证据。
  • 应报告预期与非预期后果的整体视图,并提供详细过程评价以指导成功AMS策略的实施。

研究设计与样本

  • 叙述性综述,文献来源为Cochrane与Pubmed。
  • 提供评估AMS干预研究证据质量的框架,并用于未来AMS评价研究的设计与规划阶段。

主要发现

  • AMS多在复杂真实环境中实施,偏倚与随机时间效应可危及因果推断的效度。
  • 最重要的风险包括同步实施的感染防控策略与均值回归。
  • 通过随机化干预使干预组与对照组同质可限制这些风险,但污染对AMS可能起重要作用。
  • 因此推荐整群随机化而非个体随机化;识别足够代表性集群具挑战性且cRCT实施可能昂贵。
  • 含对照组的ITS设计效度也较高且相对易实施,但应考虑时间变化的混杂。

关键数值与推荐

  • 推荐整群随机化而非个体随机化。
  • 含对照组的ITS设计效度较高且相对易实施。
  • 无论何种设计,均需纳入多项过程、临床结局、微生物学与财务指标以检测可能的非预期后果。

临床怎么用

  • 设计AMS评价研究时应优先选择cRCT或含对照组的ITS。
  • 实施中需关注同步感染防控策略、均值回归与污染等偏倚来源。
  • 报告时应呈现预期与非预期后果并附详细过程评价,以指导AMS策略落地。

局限性

  • 本文为叙述性综述,未报告定量合并结果或样本量等数值。
  • cRCT识别足够代表性集群具挑战性且实施可能昂贵。
  • ITS设计需考虑时间变化的混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: In this narrative review, we provide a framework for assessing the quality of evidence provided by studies investigating antimicrobial stewardship (AMS) interventions, and inform the design and planning stage for future AMS evaluation studies to determine the best strategies to keep antimicrobial resistance at bay. SOURCES: Cochrane/Pubmed. CONTENT: As AMS is mostly applied in a complex, real-world setting, bias and random time effects can jeopardize the validity of causal inference. The most important risks include simultaneously implemented infection prevention strategies and regression to the mean. Inclusion of homogeneous intervention and control arms, through randomization of the intervention, can limit these risks. However, contamination can play an important role for AMS; therefore, randomization at cluster-level, instead of randomization at individual-level, is recommended. It can be challenging to identify enough representative clusters, and implementation of a cluster-RCT (cRCT) can be costly. Controlled interrupted time series (ITS) design has a high validity as well, and is relatively straightforward to implement, although time-varying confounding should be considered. Independent of the study design, it is crucial to include multiple process, clinical outcome, microbiological and financial measures, to be able to detect possible, unintended consequences. IMPLICATIONS: Future studies assessing the impact of new AMS strategies should produce compelling evidence by opting for cRCTs, or ITS including a control arm. Furthermore, a holistic view of intended and unintended consequences should be reported, and a detailed process evaluation should be provided to adequately inform implementation of successful AMS strategies to battle the rising burden of AMR.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. de Kraker MEA, Abbas M, Huttner B, et al. Good epidemiological practice: a narrative review of appropriate scientific methods to evaluate the impact of antimicrobial stewardship interventions. Clin Microbiol Infect. 2017. PMID: 28571767. doi:10.1016/j.cmi.2017.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。